proteomics; accessible proteins; cancer biomarkers; glycoproteins,
Abstract :
[en] The identification of specific biomarkers obtained directly from human pathological lesions remains a major challenge, because the amount of tissue available is often very limited. We have developed a novel, comprehensive, and efficient method permitting the identification and absolute quantification of potentially accessible proteins in such precious samples. This protein subclass comprises cell membrane associated and extracellular proteins, which are reachable by systemically deliverable substances and hence especially suitable for diagnosis and targeted therapy applications. To isolate such proteins, we exploited the ability of chemically modified biotin to label ex vivo accessible proteins and the fact that most of these proteins are glycosylated. This approach consists of three successive steps involving first the linkage of potentially accessible proteins to biotin molecules followed by their purification. The remaining proteins are then subjected to glycopeptide isolation. Finally, the analysis of the nonglycosylated peptides and their involvement in an in silico method increased the confident identification of glycoproteins. The value of the technique was demonstrated on human breast cancer tissue samples originating from 5 individuals. Altogether, the method delivered quantitative data on more than 400 potentially accessible proteins (per sample and replicate). In comparison to biotinylation or glycoprotein analysis alone, the sequential method significantly increased the number (≥30% and ≥50% respectively) of potentially therapeutically and diagnostically valuable proteins. The sequential method led to the identification of 93 differentially modulated proteins, among which several were not reported to be associated with the breast cancer. One of these novel potential biomarkers was CD276, a cell membrane-associated glycoprotein. The immunohistochemistry analysis showed that CD276 is significantly differentially expressed in a series of breast cancer lesions. Due to the fact that our technology is applicable to any type of tissue biopsy, it bears the ability to accelerate the discovery of new relevant biomarkers in a broad spectrum of pathologies.
Research center :
Giga-Cancer - ULiège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Turtoi, Andrei ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Dumont, Bruno ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Greffe, Yannick; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Blomme, Arnaud ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Mazzucchelli, Gabriel ; Université de Liège - ULiège > Center for Analytical Research and Technology (CART)
Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Proteomics and biomarkers. J. Proteome Res. 2005, 4 (whole issue), 1053-1456.
Celis, J. E.; Gromov, P.; Cabezón, T.; Moreira, J. M.; Ambartsumian, N.; Sandelin, K.; Rank, F.; Gromova, I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery Mol. Cell. Proteomics 2004, 3, 327-344 (Pubitemid 38702087)
Castronovo, V.; Kischel, P.; Guillonneau, F.; de Leval, L.; Deféchereux, T.; De Pauw, E.; Neri, D.; Waltregny, D. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method Proteomics 2007, 7, 1188-1196 (Pubitemid 46716046)
Wollscheid, B.; Bausch-Fluck, D.; Henderson, C.; O'Brien, R.; Bibel, M.; Schiess, R.; Aebersold, R.; Watts, J. D. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins Nat. Biotechnol. 2009, 27 (4) 378-386
Naeem, A.; Saleemuddin, M.; Khan, R. H. Glycoprotein targeting and other applications of lectins in biotechnology Curr. Protein Pept. Sci. 2007, 8 (3) 261-271 (Pubitemid 46979728)
Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 2003, 21 (6) 660-666 (Pubitemid 36638093)
Zhang, H. Glycoproteomics using chemical immobilization Curr. Protoc. Protein Sci. 2007, 24 unit 24.3
Sun, B.; Ranish, J. A.; Utleg, A. G.; White, J. T.; Yan, X.; Lin, B.; Hood, L. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics Mol. Cell. Proteomics 2007, 6, 141-149 (Pubitemid 46152699)
Chen, R.; Jiang, X.; Sun, D.; Han, G.; Wang, F.; Ye, M.; Wang, L.; Zou, H. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry J. Proteome Res. 2009, 8, 651-661
Sprung, R. W., Jr.; Brock, J. W.; Tanksley, J. P.; Li, M.; Washington, M. K.; Slebos, R. J.; Liebler, D. C. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis Mol. Cell. Proteomics 2009, 8 (8) 1988-1998
Roth, T. J.; Sheinin, Y.; Lohse, C. M.; Kuntz, S. M.; Frigola, X.; Inman, B. A.; Krambeck, A. E.; McKenney, M. E.; Karnes, R. J.; Blute, M. L.; Cheville, J. C.; Sebo, T. J.; Kwon, E. D. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res. 2007, 67, 7893-7900 (Pubitemid 47281385)
Crispen, P. L.; Sheinin, Y.; Roth, T. J.; Lohse, C. M.; Kuntz, S. M.; Frigola, X.; Thompson, R. H.; Boorjian, S. A.; Dong, H.; Leibovich, B. C.; Blute, M. L.; Kwon, E. D. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clin. Cancer Res. 2008, 14 (16) 5150-5157
Castriconi, R.; Dondero, A.; Augugliaro, R.; Cantoni, C.; Carnemolla, B.; Sementa, A. R.; Negri, F.; Conte, R.; Corrias, M. V.; Moretta, L.; Moretta, A.; Bottino, C. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12640-12645 (Pubitemid 39122076)